Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Pain Relief & OTC Medication Recalls

Recalls of common over-the-counter and prescription pain relievers.

415 recalls in this category, newest first.

Class III · Low risk

Diclofenac Sodium Topical Solution

Defective Container: firm discovered samples stored horizontally as well as product quality complaints from customers for bottles leaking.

Terminated Packaging defect Ingenus Pharmaceuticals Llc NDC 50742-308-05 D-1058-2019
Class II · Moderate risk

Infants' Ibuprofen

Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

Terminated Wrong potency / content Tris Pharma Inc. NDC 50428-1252-4 D-0495-2019
Class II · Moderate risk

infants* IBUPROFEN

Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

Terminated Wrong potency / content Tris Pharma Inc. NDC 49035-125-24 D-0494-2019
Class II · Moderate risk

Infants' Ibuprofen

Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

Terminated Wrong potency / content Tris Pharma Inc. NDC 59779-925-23 D-0493-2019
Class II · Moderate risk

Infants' Ibuprofen

Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Terminated Wrong potency / content Tris Pharma Inc. NDC 55319-250-23 D-0336-2019
Class II · Moderate risk

infants* IBUPROFEN

Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Terminated Wrong potency / content Tris Pharma Inc. NDC 49035-125-23 D-0335-2019
Class III · Low risk

Oxycodone and Acetaminophen Tablets

Labeling: Incorrect or Missing Lot and/or Exp Date: Lot FG10517 is mislabeled on the primary container with Lot FG01517, shipper labels and invoices contain the correct lot number of FG10517.

Terminated Labeling / mix-up Mayne Pharma Inc NDC 68308-841-01 D-1129-2018
Class II · Moderate risk

RPC APAP Elixir

CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.

Terminated Microbial contamination RIJ Pharmaceutical LLC NDC 53807-129-16 D-0847-2018
Class II · Moderate risk

RPC Children's Non-Aspirin

CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.

Terminated Microbial contamination RIJ Pharmaceutical LLC NDC 53807-129-04 D-0845-2018
Class II · Moderate risk

Acetaminophen 300 mg with Codeine Phosphate 30 mg tablets

Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

Terminated Labeling / mix-up Prescript Pharmaceuticals, Inc. D-0809-2018
Class II · Moderate risk

Acetaminophen 300 mg with Codeine Phosphate 30 mg tablets

Labeling: Not Elsewhere Classified: due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

Terminated Labeling / mix-up Prescript Pharmaceuticals, Inc. D-0806-2018
Class II · Moderate risk

Tramadol HCl USP

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-8032-4 D-0529-2018
Class II · Moderate risk

Gabapentin USP for prescription compounding

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-8014-4 D-0494-2018